Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
Authors:
- Anzhalika SidarovichASAnzhalika Sidarovich
- Nadine KrügerNKNadine Krüger
- Cheila RochaCRCheila Rocha
- Luise GraichenLGLuise Graichen
- Amy KempfAKAmy Kempf
- Inga NehlmeierINInga Nehlmeier
- Martin LierMLMartin Lier
- Anne CossmannACAnne Cossmann
- Metodi V. StankovMSMetodi V. Stankov
- Sebastian R. SchulzSSSebastian R. Schulz
- Georg M. N. BehrensGBGeorg M. N. Behrens
- Hans-Martin JäckHJHans-Martin Jäck
Open Access
Abstract
The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) facilitates viral entry into host cells and is the key target for neutralizing antibodies. The SARS-CoV-2 lineage B.1.620 carries fifteen mutations in the S protein and is spread in Africa, the US and Europe, while lineage R.1 harbors four mutations in S and infections were observed in several countries, particularly Japan and the US. However, the impact of the mutations in B.1.620 and R.1 S proteins on antibody-mediated neutralization and host cell entry are largely unknown. Here, we report that these mutations are compatible with robust ACE2 binding and entry into cell lines, and they markedly reduce neutralization by vaccine-induced antibodies. Our results reveal evasion of neutralizing antibodies by B.1.620 and R.1, which might have contributed to the spread of these lineages.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (1KI2074A, 01KI2006D, 01KI20328A, 01KX2021, 01KI2043, 01KX2021, 14-76103-184, MWK HZI COVID-19, RTG1660, PO 716/11-1, PO 716/14-1, TRR130, 80018019238, ZW7-8515131)
- Bundesministerium für Forschung, Technologie und Raumfahrt (1KI2074A, 01KI2006D, 01KI20328A, 01KX2021, 01KI2043, 01KX2021, 14-76103-184, MWK HZI COVID-19, RTG1660, PO 716/11-1, PO 716/14-1, TRR130, 80018019238, ZW7-8515131)
- Niedersächsisches Ministerium für Wissenschaft und Kultur (1KI2074A, 01KI2006D, 01KI20328A, 01KX2021, 01KI2043, 01KX2021, 14-76103-184, MWK HZI COVID-19, RTG1660, PO 716/11-1, PO 716/14-1, TRR130, 80018019238, ZW7-8515131)
- Bavarian State Ministry for Science and the Arts (1KI2074A, 01KI2006D, 01KI20328A, 01KX2021, 01KI2043, 01KX2021, 14-76103-184, MWK HZI COVID-19, RTG1660, PO 716/11-1, PO 716/14-1, TRR130, 80018019238, ZW7-8515131)
- Deutsche Forschungsgemeinschaft (1KI2074A, 01KI2006D, 01KI20328A, 01KX2021, 01KI2043, 01KX2021, 14-76103-184, MWK HZI COVID-19, RTG1660, PO 716/11-1, PO 716/14-1, TRR130, 80018019238, ZW7-8515131)
- Deutsches Zentrum für Infektionsforschung (1KI2074A, 01KI2006D, 01KI20328A, 01KX2021, 01KI2043, 01KX2021, 14-76103-184, MWK HZI COVID-19, RTG1660, PO 716/11-1, PO 716/14-1, TRR130, 80018019238, ZW7-8515131)
- European Regional Development Fund (1KI2074A, 01KI2006D, 01KI20328A, 01KX2021, 01KI2043, 01KX2021, 14-76103-184, MWK HZI COVID-19, RTG1660, PO 716/11-1, PO 716/14-1, TRR130, 80018019238, ZW7-8515131)
This publication has 48 references indexed in Scilit:
- REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamstersScience, 2020
- Spike mutation D614G alters SARS-CoV-2 fitnessNature, 2020
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2Science, 2020
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeNature, 2020
- Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric virusesJournal of Experimental Medicine, 2020
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung CellsMolecular Cell, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated NeutralizationJournal of Virology, 2019
- The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cellsPLOS ONE, 2017
- A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I InterferonPLOS ONE, 2011